LETERMOVIR FOR DIFFICULT TO TREAT CYTOMEGALOVIRUS INFECTION IN LUNG TRANSPLANT RECIPIENTS

T. Veit,D. Munker,T. Kauke,P. Arnold,F. Ceelen,J. Barton,S. Michel,K. Milger,M. Zoller,J. Behr,N. Kneidinger

TRANSPLANT INTERNATIONAL（2019）

引用 20|浏览5

暂无评分

摘要

Background: Cytomegalovirus (CMV)-infection remains a major cause of morbidity and mortality after lung transplantation. Treatment with currently available drugs poses treatment difficulties in some patients due to drug resistance or intolerability.

查看译文

关键词

cytomegalovirus infection

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要